4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000033
CEO sold 1,000 shares at $16.17 ($16,174)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Doshi Dipal CEO | 2024-06-13 | Sale 10b5-1 | −1,000 | $16.17 | $16,174 | 336,375 | D |
| Open-market sales · 1,000 sh · avg $16.17 · $16,174 | |||||||
Loading xslF345X05/wk-form4_1718397122.xml…